These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25517716)

  • 1. Ivabradine in stable coronary artery disease.
    Fox K; Ford I; Ferrari R
    N Engl J Med; 2014 Dec; 371(25):2435. PubMed ID: 25517716
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine in stable coronary artery disease.
    Stulc T; Ceska R
    N Engl J Med; 2014 Dec; 371(25):2435. PubMed ID: 25517717
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease: Stable CAD does not SIGNIFY ivabradine therapy.
    Lim GB
    Nat Rev Cardiol; 2014 Nov; 11(11):621. PubMed ID: 25223448
    [No Abstract]   [Full Text] [Related]  

  • 5. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the SIGNIFY trial.
    Grassi G
    Expert Opin Pharmacother; 2015; 16(12):1861-4. PubMed ID: 26153241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine, coronary heart disease, and heart failure: time for reappraisal.
    Stulc T; Ceška R
    Curr Atheroscler Rep; 2014 Dec; 16(12):463. PubMed ID: 25301354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
    Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
    Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
    Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
    Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
    Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.
    Heusch G; Kleinbongard P
    Drugs; 2016 May; 76(7):733-40. PubMed ID: 27041289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges with chronic angina.
    Ohman EM; Alexander KP
    N Engl J Med; 2014 Sep; 371(12):1152-3. PubMed ID: 25176137
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.